Alaunos Therapeutics (TCRT) Change in Receivables (2016 - 2025)
Historic Change in Receivables for Alaunos Therapeutics (TCRT) over the last 15 years, with Q3 2025 value amounting to -$2000.0.
- Alaunos Therapeutics' Change in Receivables rose 5000.0% to -$2000.0 in Q3 2025 from the same period last year, while for Jun 2025 it was -$2000.0, marking a year-over-year change of. This contributed to the annual value of $4000.0 for FY2024, which is 23333.33% up from last year.
- Alaunos Therapeutics' Change in Receivables amounted to -$2000.0 in Q3 2025, which was up 5000.0% from -$3000.0 recorded in Q1 2025.
- In the past 5 years, Alaunos Therapeutics' Change in Receivables ranged from a high of $2.9 million in Q3 2022 and a low of -$6.1 million during Q3 2021
- Over the past 5 years, Alaunos Therapeutics' median Change in Receivables value was -$2500.0 (recorded in 2025), while the average stood at -$291625.0.
- In the last 5 years, Alaunos Therapeutics' Change in Receivables crashed by 62675.0% in 2022 and then surged by 40000.0% in 2024.
- Over the past 5 years, Alaunos Therapeutics' Change in Receivables (Quarter) stood at -$400000.0 in 2021, then crashed by 626.75% to -$2.9 million in 2022, then surged by 100.03% to $1000.0 in 2023, then surged by 400.0% to $5000.0 in 2024, then tumbled by 140.0% to -$2000.0 in 2025.
- Its Change in Receivables stands at -$2000.0 for Q3 2025, versus -$3000.0 for Q1 2025 and $5000.0 for Q4 2024.